,,ii #aaith ,,congress #ast ,session ,s4 #bjgb ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,june #ab1 #bjbe,mr4 ,blumenthal 7for himself1 ,mr4 ,fetterman1 ,mr4 ,heinrich1 ,mr4 ,lujn1 ,ms4 ,klobuchar1 and ,mr4 ,welch7 introduced the following bill2 which was read twice and referred to the ,committee on ,finance ,a ,,bill ,to promote affordable access to evidence-based opioid treatments under the ,medicare program and require coverage of medication assisted treatment for opioid use disorders1 opioid overdose reversal medications1 and recovery support services by health plans without cost-sharing requirements4 #a4 ,short title ,this ,act may be cited as the ,maximizing ,opioid ,recovery ,emergency ,savings ,act or the ,,more ,savings ,act4 #b4 ,testing of elimination of ,medicare cost-sharing for evidence-based opioid treatments ,section #aaae;,a7b77#b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acae;a7b77#b77 is amended-- 7#a7 in subparagraph 7,a71 in the last sentence1 by inserting 1 and shall include the model described in subparagraph 7,d7 7which shall be implemented by not later than six months after the date of the enactment of the ,maximizing ,opioid ,recovery ,emergency ,savings ,act7 before the period at the end2 and 7#b7 by adding at the end the following new subparagraph3 7,d7 ,affordable access to evidence-based opioid treatments 7i7 ,in general ,the model described in this subparagraph is a model that seeks to provide affordable access to evidence-based opioid treatments and community-based recovery support services by eliminating coinsurance1 copayments1 and deductibles otherwise applicable under parts ,b and ,d of title ,,xviii 7including as such parts are applied under part ,c of such title7 for the following items and services that are otherwise covered under such parts3 7,i7 ,drugs and biologicals prescribed or furnished to treat opioid use disorders or reverse overdose4 7,,ii7 ,behavioral health and community support services furnished for the treatment of opioid use disorders1 including treatment of addiction in non-hospital residential facilities licensed to furnish such treatment4 7,,iii7 ,recovery support services to maintain a healthy lifestyle following opioid misuse treatment1 such as peer counseling and transportation4 7ii7 ,selection of sites ,the ,,cmi shall select #ae ,states in which to conduct the model under this subparagraph4 ,a ,state shall meet each of the following criteria in order to be selected under the preceding sentence3 7,i7 ,the ,state has a high proportion of ,medicare beneficiaries4 7,,ii7 ,the ,state has a high rate of overdose deaths due to opioids4 7,,iii7 ,the ,state has a significant percentage of rural areas4 7iii7 ,termination and modification provision not applicable for first five years of the model ,the provisions of paragraph 7#c77;,b7 shall apply to the model under this subparagraph beginning on the date that is five years after such model is implemented1 but shall not apply to such model prior to such date4 4 #c4 ,coverage of opioid treatments 7a7 ,in general 7#a7 ,,phsa ,part ,d of title ,,xxvii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg-#aaa et seq47 is amended by adding at the end the following3 #bgii;,a-#aa4 ,coverage of opioid treatments ,a group health plan and a health insurance issuer offering group or individual health insurance coverage shall1 at a minimum1 with respect to a participant1 beneficiary1 or enrollee in the plan or coverage1 provide coverage for and shall not impose any cost-sharing requirements for-- 7#a7 prescription drugs for the treatment of opioid use disorders or to reverse overdose2 7#b7 behavioral health services for the treatment of opioid use disorders1 including treatment of opioid use disorders in non-hospital residential facilities licensed to provide such treatment2 or 7#c7 community recovery support services that are provided in conjunction with1 where appropriate1 medication-assisted treatment for an opioid use disorder1 such as peer counseling and transportation1 to support the participant1 beneficiary1 or enrollee in maintaining a healthy lifestyle following opioid misuse treatment4 4 7#b7 ,,erisa 7,a7 ,in general ,subpart ,b of part #g of subtitle ,b of title ,i of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #aahe et seq47 is amended by adding at the end the following3 #gbf4 ,coverage of opioid treatments ,a group health plan and a health insurance issuer offering group health insurance coverage shall1 at a minimum1 with respect to a participant or beneficiary in the plan or coverage1 provide coverage for and shall not impose any cost-sharing requirements for-- 7#a7 prescription drugs for the treatment of opioid use disorders or to reverse overdose2 7#b7 behavioral health services for the treatment of opioid use disorders1 including treatment of opioid use disorders in non-hospital residential facilities licensed to provide such treatment2 or 7#c7 community recovery support services that are provided in conjunction with1 where appropriate1 medication-assisted treatment for an opioid use disorder1 such as peer counseling and transportation1 to support the participant or beneficiary in maintaining a healthy lifestyle following opioid misuse treatment4 4 7,b7 ,clerical amendment ,the table of contents in section #a of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #ajja et seq47 is amended by inserting after the item relating to section #gbe the following new item3 ,sec4 #gbf4 ,coverage of opioid treatments4 4 7#c7 ,,irc 7,a7 ,in general ,chapter #ajj of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following3 #ihbf4 ,coverage of opioid treatments ,a group health plan shall1 at a minimum1 with respect to a participant or beneficiary in the plan1 provide coverage for and shall not impose any cost-sharing requirements for-- 7#a7 prescription drugs for the treatment of opioid use disorders or to reverse overdose2 7#b7 behavioral health services for the treatment of opioid use disorders1 including treatment of opioid use disorders in non-hospital residential facilities licensed to provide such treatment2 or 7#c7 community recovery support services that are provided in conjunction with1 where appropriate1 medication-assisted treatment for an opioid use disorder1 such as peer counseling and transportation1 to support the participant or beneficiary in maintaining a healthy lifestyle following opioid misuse treatment4 4 7,b7 ,clerical amendment ,the table of sections for subchapter ,b of chapter #ajj of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new item3 ,sec4 #ihbf4 ,coverage of opioid treatments44 7b7 ,effective date ,the amendments made by subsection 7a7 shall apply with respect to plan years beginning on or after ,january #a1 #bjbg4 #d4 ,enhanced ,federal match for medication-assisted treatment and recovery support services under ,medicaid 7a7 ,in general ,section #aije7;b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;d7b77 is amended by adding at the end the following3 ,notwithstanding the first sentence of this subsection1 during the portion of the period described in subsection 7a77#bi7 that begins on the date of enactment of this sentence1 the ,federal medical assistance percentage shall be #ij percent with respect to amounts expended during such portion of such period by a ,state that is one of the #ej ,states or the ,district of ,columbia as medical assistance for medication-assisted treatment 7as defined in subsection 7ee77#a7744 7b7 ,state option ,to provide recovery support services as part of medication-,assisted treatment ,section #aije7;ee77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;d7ee77#a77 is amended-- 7#a7 in subparagraph 7,a71 by striking 2 and and inserting a semicolon2 7#b7 in subparagraph 7,b71 by striking the period at the end and inserting 2 and2 and 7#c7 by adding at the end the following new subparagraph3 7,c7 at the option of a ,state1 includes recovery support services1 such as peer counseling and transportation1 that are provided to an individual in conjunction with the provision of such drugs and biological products to support the individual in maintaining a healthy lifestyle following opioid misuse treatment4 4